Clinical trial NCT07515456, theophylline vs sumatriptan, gabapentin
Summary
NIH National Library of Medicine registered clinical trial NCT07515456 on ClinicalTrials.gov. The trial is a Phase 2/3 randomized study evaluating theophylline compared to sumatriptan and gabapentin for an undisclosed condition, enrolling approximately 60 participants aged 18-65.
What changed
A new clinical trial registration for NCT07515456 was posted to the ClinicalTrials.gov public registry. The trial will study theophylline versus sumatriptan and gabapentin as comparators in a randomized design.
For sponsors, clinical investigators, and pharmaceutical companies, this registry entry provides visibility into ongoing comparative effectiveness research for these generic pharmaceutical compounds. No immediate compliance actions are required; however, organizations conducting similar research should be aware of this competitive trial.
What to do next
- Monitor ClinicalTrials.gov for updated enrollment status and results
Source document (simplified)
Show glossary
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.